NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Goyang-si, Gyeonggi-do, South Korea1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers | Unresectable Bile Duct Carcinoma; Unresectable Biliary Tract Carcinoma; Unresectable Pancreatic Cancer | Recruiting | Phase 2 | 2025-06-18 | NCT06135896 |